CVRx Analyst Ratings
Cantor Fitzgerald Maintains CVRx Inc(CVRX.US) With Buy Rating, Maintains Target Price $14
Craig-Hallum Maintains CVRx Inc(CVRX.US) With Buy Rating
Lake Street Maintains CVRx Inc(CVRX.US) With Buy Rating, Maintains Target Price $12
CCORF Maintains CVRx Inc(CVRX.US) With Buy Rating, Maintains Target Price $15
Craig-Hallum Maintains CVRx Inc(CVRX.US) With Buy Rating
Cantor Fitzgerald Initiates Coverage On CVRx With Overweight Rating, Announces Price Target of $14
Cantor Fitzgerald Initiates CVRx Inc(CVRX.US) With Buy Rating, Announces Target Price $14
Lake Street Maintains CVRx Inc(CVRX.US) With Buy Rating, Maintains Target Price $12
CCORF Maintains CVRx Inc(CVRX.US) With Buy Rating, Maintains Target Price $15
CVRx Price Target Maintained With a $12.00/Share by Lake Street
CVRx Analyst Ratings
Lake Street Reiterates Buy on CVRx, Maintains $12 Price Target
Lake Street Maintains CVRx Inc(CVRX.US) With Buy Rating, Maintains Target Price $12
Lake Street Maintains CVRx Inc(CVRX.US) With Buy Rating, Maintains Target Price $12
Lake Street Maintains CVRx Inc(CVRX.US) With Buy Rating, Maintains Target Price $12
Lake Street Remains a Buy on CVRx (CVRX)
Lake Street Maintains CVRx Inc(CVRX.US) With Buy Rating, Maintains Target Price $12
Analysts Offer Insights on Healthcare Companies: CVRx (CVRX), Adaptive Biotechnologies (ADPT) and Rezolute (RZLT)
Lake Street Keeps Their Buy Rating on CVRx (CVRX)